Sergey Denisov

Sergey is investment associate at Altair Capital Management he used a large number of tools and different skills to evaluate asset selection strategies and to get deep BlockChainmarket knowledge. Sergey recommends investment options and decision-making approaches to the board of directors.

Prior to joining the firm Sergey has held a number of analytical leadership positions throughout his career. As an early employee at Hexal AG Russia, which was acquired by Novartis globally, Sergey leads several analytical projects implementations across CIS and Europe. Sergey managed regular reporting for Novartis group and later for Renaissance insurance company. He is experienced in corporate strategy development for healthcare, insurance, and IT industries.